| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | AF75XOF6W3 |
Pharmacology
| Primary Target | |
|---|---|
| LAG3 (CD223) |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Gliosarcoma | 1 | D018316 | ClinicalTrials |
| Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1673516-98-7 |
| ChEMBL | CHEMBL3990044 |
| FDA SRS | AF75XOF6W3 |
| Guide to Pharmacology | 9536 |
CONTENTS